BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Z, Yang L. Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts. J Ethnopharmacol 2021;270:113869. [PMID: 33485973 DOI: 10.1016/j.jep.2021.113869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, Yang L. Broad-spectrum prodrugs with anti-SARS-CoV-2 activities: Strategies, benefits, and challenges. J Med Virol 2021. [PMID: 34897729 DOI: 10.1002/jmv.27517] [Reference Citation Analysis]
2 Yang L, Wang Z. Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer. Biomedicines 2021;9:689. [PMID: 34207313 DOI: 10.3390/biomedicines9060689] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Alotiby A, Alshareef M. Comparison Between Healthcare Professionals and the General Population on Parameters Related to Natural Remedies Used During the COVID-19 Pandemic. J Multidiscip Healthc 2021;14:3523-32. [PMID: 34992379 DOI: 10.2147/JMDH.S343140] [Reference Citation Analysis]
4 Liang XX, Zhang XJ, Zhao YX, Feng J, Zeng JC, Shi QQ, Kaunda JS, Li XL, Wang WG, Xiao WL. Aspulvins A-H, Aspulvinone Analogues with SARS-CoV-2 Mpro Inhibitory and Anti-inflammatory Activities from an Endophytic Cladosporium sp. J Nat Prod 2022. [PMID: 35293744 DOI: 10.1021/acs.jnatprod.1c01003] [Reference Citation Analysis]
5 Wang Z, Yang L. Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue. Front Public Health 2022;10:908757. [DOI: 10.3389/fpubh.2022.908757] [Reference Citation Analysis]
6 Omer AK, Khorshidi S, Mortazavi N, Rahman HS. A Review on the Antiviral Activity of Functional Foods Against COVID-19 and Viral Respiratory Tract Infections. IJGM 2022;Volume 15:4817-35. [DOI: 10.2147/ijgm.s361001] [Reference Citation Analysis]
7 de Oliveira OV, Cristina Andreazza Costa M, Marques da Costa R, Giordano Viegas R, Paluch AS, Miguel Castro Ferreira M. Traditional herbal compounds as candidates to inhibit the SARS-CoV-2 main protease: an in silico study. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2021.2023646] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lyu M, Fan G, Xiao G, Wang T, Xu D, Gao J, Ge S, Li Q, Ma Y, Zhang H, Wang J, Cui Y, Zhang J, Zhu Y, Zhang B. Traditional Chinese medicine in COVID-19. Acta Pharm Sin B 2021;11:3337-63. [PMID: 34567957 DOI: 10.1016/j.apsb.2021.09.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
9 Yu R, Li P. Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking. J Virol Methods 2021;301:114424. [PMID: 34896453 DOI: 10.1016/j.jviromet.2021.114424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhang H, Cao Z, Sun P, Khan A, Guo J, Sun Y, Yu X, Fan K, Yin W, Li E, Sun N, Li H. A novel strategy for optimal component formula of anti-PRRSV from natural compounds using tandem mass tag labeled proteomic analyses. BMC Vet Res 2022;18:179. [PMID: 35568854 DOI: 10.1186/s12917-022-03184-w] [Reference Citation Analysis]
11 Xu X, Wang S, Wang H, Hu W, Han L, Chen B, Li X, Wang H, Li H, Gao X, Guo D, Yang W. Simultaneous quantitative assays of 15 ginsenosides from 119 batches of ginseng samples representing 12 traditional Chinese medicines by ultra-high performance liquid chromatography coupled with charged aerosol detector. J Chromatogr A 2021;1655:462504. [PMID: 34487881 DOI: 10.1016/j.chroma.2021.462504] [Reference Citation Analysis]
12 Liu X, Lou L, Zhou L. Molecular Mechanisms of Cardiac Injury Associated With Myocardial SARS-CoV-2 Infection. Front Cardiovasc Med 2022;8:643958. [DOI: 10.3389/fcvm.2021.643958] [Reference Citation Analysis]
13 Joseph SM, Iyer DS, Pillai RV. Ayurvedic Response to COVID-19 Pandemic in Kerala, India and Its Impact on Quarantined Individuals - A Community Case Study. Front Public Health 2021;9:732523. [PMID: 34722442 DOI: 10.3389/fpubh.2021.732523] [Reference Citation Analysis]
14 Wang Z, Yang L, Zhao XE. Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery. Comput Struct Biotechnol J 2021;19:4684-701. [PMID: 34426762 DOI: 10.1016/j.csbj.2021.08.029] [Reference Citation Analysis]
15 Liana D, Phanumartwiwath A. Leveraging knowledge of Asian herbal medicine and its active compounds as COVID-19 treatment and prevention. J Nat Med 2021. [PMID: 34623617 DOI: 10.1007/s11418-021-01575-1] [Reference Citation Analysis]
16 Lou H, Li X, Gao S, Zhang Y, Chen H, Zhai X. Identifying Potential Gene Defect Patterns Related to COVID-19 Based on Pharmacological and Bioinformatics Analysis for Lung Adenocarcinoma. IJGM 2022;Volume 15:4285-301. [DOI: 10.2147/ijgm.s356444] [Reference Citation Analysis]
17 Xiong Y, Zhu GH, Zhang YN, Hu Q, Wang HN, Yu HN, Qin XY, Guan XQ, Xiang YW, Tang H, Ge GB. Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms. Int J Biol Macromol 2021;187:976-87. [PMID: 34333006 DOI: 10.1016/j.ijbiomac.2021.07.167] [Reference Citation Analysis]
18 Li Y, Li B, Wang P, Wang Q. Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production via NF-κB Signaling Pathway in Macrophages: Implications for Coronavirus Disease 2019 (COVID-19) Therapy. Front Pharmacol 2021;12:722126. [PMID: 34764867 DOI: 10.3389/fphar.2021.722126] [Reference Citation Analysis]